EcoDrugPlus

G1/s-Specific Cyclin-D1-Like

Ensembl ID : ENSSMAG00000003806
Gene Symbol: LOC118314882
2 Cross references
206 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSMAG00000000875
Gene Symbol: HCK
3 Cross references
202 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSSMAG00000009682
Gene Symbol: ITK
3 Cross references
205 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1b

Ensembl ID : ENSSMAG00000002059
Gene Symbol: IMPDH1B
2 Cross references
257 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 2

Ensembl ID : ENSSMAG00000010373
Gene Symbol: IMPDH2
1 Cross references
200 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSSMAG00000020659
Gene Symbol: JAK1
1 Cross references
212 Possible Orthologues:

Janus Kinase 2a

Ensembl ID : ENSSMAG00000020074
Gene Symbol: JAK2A
3 Cross references
199 Possible Orthologues:

Janus Kinase 2b

Ensembl ID : ENSSMAG00000008678
Gene Symbol: JAK2B
2 Cross references
194 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSMAG00000015483
Gene Symbol: LYN
3 Cross references
195 Possible Orthologues:

Malt Paracaspase 1

Ensembl ID : ENSSMAG00000008414
Gene Symbol: MALT1
2 Cross references
195 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSSMAG00000005790
Gene Symbol: MAPKAPK2
1 Cross references
187 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2b

Ensembl ID : ENSSMAG00000020917
Gene Symbol: MKNK2B
3 Cross references
208 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).